размер, стоимость, обзор и тенденции отрасли офтальмологии к 2030 году

Global Ophthalmology Market

Размер рынка в млрд долларов США

CAGR : 6.70 %

USD 78.28 Billion USD 130.74 Billion 2024 2032

Прогнозируемый период	2025 –2032
Размер рынка (базовый год)	USD 78.28 Billion
Размер рынка (прогнозируемый год)	USD 130.74 Billion
CAGR	6.70 %
Основные игроки рынка	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Запрос на разблокировку

>Сегментация мирового рынка офтальмологии, побочные продукты (устройства, лекарства и другие), заболевания (катаракта, рефракционные нарушения, глаукома, возрастная макулярная дегенерация, воспалительные заболевания и другие), комплексное обследование глаз (рефракция, проверка остроты зрения, внутриглазное давление, обследование переднего сегмента и зрачка, проверка полей зрения, проверка цветового зрения и другие), конечный пользователь (клиники, больницы, домашняя медицинская помощь и другие), канал сбыта (розничные продажи, прямые торги и другие) — тенденции отрасли и прогноз до 2032 г.

Get Exclusive Sample PDF of this Report Here

Анализ мирового рынка офтальмологии

Глобальный рынок офтальмологии значительно развивался на протяжении столетий, начиная с древних методов лечения заболеваний глаз в Египте и Греции. Эта область начала формироваться в 17-м и 18-м веках с развитием более совершенных хирургических методов и инструментов. В 19-м веке такие инновации, как офтальмоскоп, преобразили диагностические возможности. В 20-м веке произошли такие прорывы, как хирургия катаракты и изобретение интраокулярных линз, а также появление хирургии LASIK в 1990-х годах. В 21-м веке наблюдался непрерывный рост, обусловленный старением населения, технологическими достижениями и разработкой специализированных диагностических и хирургических устройств, включая оптическую когерентную томографию (ОКТ) и системы визуализации сетчатки. Последние тенденции сосредоточены на все более широком использовании искусственного интеллекта, телемедицины и биологических методов лечения, таких как генная терапия и лечение стволовыми клетками, что еще больше формирует рост рынка. Сегодня рынок офтальмологии продолжает расширяться благодаря росту распространенности заболеваний глаз, появлению новых технологий и развитию вариантов лечения.

Get Exclusive Sample PDF of this Report Here

Размер мирового рынка офтальмологии

Ожидается, что мировой рынок офтальмологии достигнет 130,74 млрд долларов США к 2032 году по сравнению с 78,28 млрд долларов США в 2024 году, а среднегодовой темп роста составит 6,7% в прогнозируемый период с 2025 по 2032 год.

Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают анализ импорта и экспорта, обзор производственных мощностей, анализ потребления продукции, анализ ценовых тенденций, сценарий изменения климата, анализ цепочки поставок, анализ цепочки создания стоимости, обзор сырья и расходных материалов, критерии выбора поставщиков, анализ PESTLE, анализ Портера и нормативную базу.

Тенденции мирового рынка офтальмологии

«Повышенная безопасность и эффективность шприцев, предварительно заполненных физиологическим раствором»

Мировой рынок офтальмологии переживает устойчивый рост, обусловленный ростом распространенности заболеваний глаз, технологическими достижениями и старением населения. Рост таких заболеваний, как катаракта, глаукома, диабетическая ретинопатия и возрастная макулярная дегенерация, способствует росту спроса на лечение глаз. Старение населения мира особенно влияет на эту тенденцию, поскольку пожилые люди более склонны к проблемам со зрением. Кроме того, достижения в диагностических технологиях, таких как оптическая когерентная томография (ОКТ), фундус-камеры и системы на базе искусственного интеллекта, повышают точность и эффективность диагностики. Малоинвазивные хирургические методы, включая лазерную терапию и роботизированные операции, набирают популярность, предлагая более быстрое время восстановления и улучшенные результаты для пациентов. Кроме того, рост персонализированной медицины в офтальмологии с таргетной терапией для таких состояний, как заболевания сетчатки, также играет ключевую роль. Внедрение новых систем доставки лекарств, таких как инъекционные биопрепараты и имплантаты с пролонгированным высвобождением, повышает эффективность лечения, особенно при хронических заболеваниях. Телемедицина — еще одна растущая тенденция на рынке офтальмологии, поскольку удаленные консультации и виртуальные скрининги становятся все более распространенными, что улучшает доступ к медицинской помощи в недостаточно обслуживаемых регионах. Ключевые игроки рынка сосредоточены на исследованиях и разработках для расширения своих продуктовых портфелей, в то время как развивающиеся рынки видят повышенный спрос на недорогие, доступные решения для ухода за глазами. С акцентом на инновации, улучшение ухода за пациентами и расширение доступа к здравоохранению рынок офтальмологии настроен на значительный рост в ближайшие годы.

Область применения отчета и сегментация мирового рынка офтальмологии

Атрибуты	Анализ мирового рынка офтальмологии
Охваченные сегменты	По видам продукции : устройства, лекарства и прочее По заболеваниям : катаракта, рефракционные нарушения, глаукома, возрастная макулярная дегенерация, воспалительные заболевания и другие Комплексное обследование глаз : рефракция, проверка остроты зрения, внутриглазное давление, обследование переднего сегмента и зрачка, проверка полей зрения, проверка цветового зрения и другие Конечным пользователем : клиники, больницы, домашняя медицинская помощь и другие По каналу сбыта : розничные продажи, прямые торги и другие
Страны, охваченные	США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Испания, Швейцария, Россия, Бельгия, Нидерланды, Турция, остальные страны Европы, Китай, Индия, Япония, Южная Корея, Австралия, Индонезия, Таиланд, Малайзия, Филиппины, Сингапур, остальные страны Азиатско-Тихоокеанского региона, Бразилия, Аргентина, остальные страны Южной Америки, Южная Африка, Саудовская Аравия, ОАЭ, Египет, Израиль и остальные страны Ближнего Востока и Африки
Ключевые игроки рынка	Alcon (Швейцария), Bausch + Lomb (Канада), Carl Zeiss Meditec (Германия), Hoya Corporation (Япония), Johnson & Johnson Services, Inc. (США), Essilor International (Франция), Topcon Corporation (Япония), Glaukos Corporation (США), Haag-Streit Group (Швейцария), Nidek Co., Ltd (США), Staar Surgical (Калифорния), Ziemer Ophthalmic Systems Ag (Швейцария), Cooper Companies (США), Lumenis Be Ltd. (Израиль), Reichert Inc. (Нью-Йорк), Bayer Ag (Германия), Novartis Ag (Швейцария), Abbvie Inc. (США), F. Hoffmann-La Roche Ltd. (Швейцария), Dompé (Италия), Santen Pharmaceutical Co. (Япония), Ltd и другие
Возможности рынка	Рост старения населения Рост популярности платформ онлайн-торговли и электронного здравоохранения Расширенное обучение пациентов
Информационные наборы данных с добавленной стоимостью	Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают анализ импорта и экспорта, обзор производственных мощностей, анализ потребления продукции, анализ ценовых тенденций, сценарий изменения климата, анализ цепочки поставок, анализ цепочки создания стоимости, обзор сырья и расходных материалов, критерии выбора поставщиков, анализ PESTLE, анализ Портера и нормативную базу.

Get Exclusive Sample PDF of this Report Here

Определение мирового рынка офтальмологии

Офтальмология — это раздел медицины и хирургии, который фокусируется на диагностике, лечении и профилактике глазных расстройств и заболеваний. Она включает в себя медицинскую и хирургическую помощь при состояниях, влияющих на глаза и зрительную систему, таких как катаракта, глаукома, дегенерация желтого пятна и диабетическая ретинопатия.

Динамика определения мирового рынка офтальмологии

Драйверы

Рост распространенности глазных заболеваний

Растущая распространенность заболеваний глаз, таких как катаракта, дегенерация желтого пятна и диабетическая ретинопатия, является важным фактором развития мирового рынка офтальмологии. По мере старения населения мира заболеваемость этими заболеваниями растет. Катаракта, которая приводит к нечеткости зрения и слепоте, требует расширения рынка хирургических операций и корректирующих процедур. Аналогичным образом, дегенерация желтого пятна и диабетическая ретинопатия способствуют потребности в передовых диагностических инструментах и специализированных методах лечения. Растущее число больных обеспечивает устойчивый спрос на услуги по уходу за глазами, включая операции, лекарства и инновационные диагностические технологии. Этот всплеск заболеваний глаз напрямую стимулирует расширение рынка, поскольку поставщики медицинских услуг и производители стремятся удовлетворить растущую потребность в эффективных методах лечения и решениях.

Например,

В июле 2022 года, согласно статье, опубликованной NCBI, распространенность слепоты увеличивается с возрастом, увеличиваясь с 0,45% у лиц в возрасте 50-59 лет до 11,62% у лиц в возрасте 80 лет и старше. Женщины (2,31%) и жители сельской местности (2,14%) испытывают более высокие показатели. Нарушения зрения также затрагивают 26,68% участников, демонстрируя схожие тенденции. Это растущее бремя глазных заболеваний, особенно среди пожилых людей, стимулирует спрос на офтальмологическое лечение и технологии, стимулируя рынок офтальмологии
Согласно статье, опубликованной ВОЗ, в августе 2023 года более 2,2 миллиарда человек во всем мире страдают от нарушений зрения, причем около 1 миллиарда случаев можно было предотвратить или не лечить. Эта растущая распространенность проблем со зрением подчеркивает растущий спрос на услуги по уходу за глазами, лечение и корректирующие решения. Поскольку все больше людей обращаются за медицинской помощью по поводу предотвратимых или невылеченных состояний, растущее бремя глазных заболеваний выступает в качестве существенного драйвера для рынка офтальмологии

Растущая распространенность возрастных заболеваний глаз, таких как катаракта, дегенерация желтого пятна и диабетическая ретинопатия, подпитывает мировой рынок офтальмологии. По мере старения населения эти заболевания становятся более распространенными, увеличивая спрос на лечение, операции и диагностические инструменты. Потребность в передовых технологиях и методах лечения растет, поскольку все больше людей нуждаются в уходе. Этот всплеск заболеваний глаз стимулирует рост рынка, поскольку поставщики медицинских услуг и производители стремятся удовлетворить растущий спрос на эффективные решения.

Фокус на профилактическом уходе за глазами

Все больше внимания уделяется профилактическому уходу за глазами и раннему выявлению проблем со зрением, что играет важную роль в развитии мирового рынка офтальмологии. По мере того, как растет осведомленность о важности здоровья глаз, все больше людей стремятся проходить плановые проверки зрения для выявления таких заболеваний, как глаукома, диабетическая ретинопатия и катаракта на ранних стадиях. Ранняя диагностика позволяет своевременно вмешаться, снизить риск потери зрения и улучшить общее состояние здоровья глаз. Этот проактивный подход не только улучшает результаты лечения пациентов, но и стимулирует спрос на офтальмологические услуги, диагностические инструменты и корректирующие процедуры. Растущее внимание к профилактическому уходу приводит к резкому росту инвестиций в технологии ухода за глазами, офтальмологические устройства и услуги, тем самым способствуя расширению рынка. Эта тенденция в значительной степени выступает в качестве движущей силы роста в секторе офтальмологии.

Например,

В октябре 2022 года, согласно статье, опубликованной Национальным институтом глаз, Национальная программа образования в области здоровья глаз (NEHEP) сотрудничает с медицинскими работниками для повышения осведомленности о раннем выявлении, лечении заболеваний глаз и преимуществах реабилитации зрения. Она также нацелена на группы населения с высоким риском заболеваний глаз и потери зрения. Такой акцент на профилактической помощи побуждает людей своевременно проходить осмотры и лечение глаз, стимулируя спрос на офтальмологические услуги, диагностические инструменты и продукты, тем самым подпитывая рынок офтальмологии
В октябре 2024 года, согласно статье, опубликованной Генеральным директоратом служб здравоохранения, Национальная программа по контролю за слепотой и нарушениями зрения (NPCB&VI) направлена на снижение распространенности слепоты путем выявления и лечения излечимой слепоты на всех уровнях здравоохранения. Сосредоточившись на раннем выявлении и решении проблемы предотвратимой слепоты, программа подчеркивает важность профилактической помощи. Эта инициатива стимулирует спрос на услуги по уходу за глазами, диагностические инструменты и методы лечения, внося значительный вклад в рост мирового рынка офтальмологии

Растущее внимание к профилактическому уходу за глазами и раннему выявлению значительно стимулирует мировой рынок офтальмологии. По мере роста осведомленности о здоровье глаз все больше людей выбирают регулярные осмотры глаз для раннего выявления таких состояний, как глаукома и катаракта. Раннее выявление позволяет проводить эффективное лечение, предотвращающее дальнейшую потерю зрения. Этот проактивный подход стимулирует спрос на диагностические инструменты, офтальмологические услуги и корректирующие процедуры. Растущая важность профилактического ухода побуждает инвестировать в передовые технологии ухода за глазами, тем самым способствуя общему росту рынка офтальмологии и обеспечивая его постоянное расширение.

Get Exclusive Sample PDF of this Report Here

Возможности

Рост старения населения

Рост стареющего населения представляет собой значительную возможность для мирового рынка офтальмологии, поскольку пожилые люди более восприимчивы к различным глазным расстройствам и заболеваниям. Такие состояния, как катаракта, возрастная макулярная дегенерация (ВМД), диабетическая ретинопатия и глаукома, распространены среди пожилых людей, что создает значительный спрос на офтальмологическую помощь и лечение. В результате системы здравоохранения и поставщики офтальмологических услуг готовы расширить свои услуги, улучшить диагностические и терапевтические возможности и удовлетворить уникальные потребности этой демографической группы. Эта растущая база пациентов требует множества решений, от хирургических вмешательств и передовой лекарственной терапии до средств коррекции зрения, что обеспечивает устойчивый и растущий спрос на офтальмологические процедуры и продукты.

Например,

В марте 2023 года, согласно статье, опубликованной в Национальной медицинской библиотеке, катаракта является основной причиной нарушения зрения в пожилом возрасте. Помутнение хрусталика, как известно, связано с несколькими гериатрическими состояниями, включая слабость, риск падения, депрессию и когнитивные нарушения. Более того, по данным того же источника, в 2020 году основными мировыми причинами слепоты у пациентов в возрасте 50 лет и старше были катаракта, за которой следовали глаукома, недостаточно скорректированная рефракционная ошибка, возрастная макулярная дегенерация и диабетическая ретинопатия.
В августе 2022 года, согласно статье, опубликованной в Американской академии офтальмологии, ВМД является распространенным заболеванием глаз, обычно встречающимся у взрослых старше 50 лет. Более того, утверждается, что у половины американцев старше 75 лет развивается катаракта.

Более того, удовлетворение потребностей в здоровье глаз у стареющего населения может стимулировать дальнейшие инвестиции в исследования и разработки в секторе офтальмологии. Фармацевтические компании и производители медицинских приборов сосредоточены на создании инновационных решений, специально разработанных для возрастных состояний, что может привести к прорывам в протоколах лечения и уходе за пациентами. Интеграция новых технологий, таких как телеофтальмология и передовые методы визуализации, способствует лучшему управлению здоровьем глаз у пожилых людей, облегчая мониторинг и лечение заболеваний удаленно. В целом, стареющее население усиливает потребность в существующих офтальмологических услугах и представляет собой благодатную почву для инноваций и роста на мировом рынке офтальмологии.

Рост популярности платформ онлайн-торговли и электронного здравоохранения

Рост онлайн-торговли и платформ электронного здравоохранения открывает значительные возможности для мирового рынка офтальмологии, предоставляя потребителям более легкий доступ к широкому спектру товаров и услуг по уходу за глазами. С ростом популярности электронной коммерции пациенты могут удобно приобретать такие товары, как очки по рецепту, контактные линзы и безрецептурные товары по уходу за глазами, не выходя из дома. Эта тенденция особенно привлекательна для молодых, технически подкованных потребителей и для тех, кто живет в отдаленных районах с ограниченным доступом к традиционным магазинам оптики. Возможность сравнивать цены, читать обзоры и получать доступ к более широкому ассортименту товаров онлайн повышает удовлетворенность клиентов и стимулирует использование, тем самым стимулируя рост в сегменте офтальмологических товаров.

Например,

В сентябре 2023 года, согласно новостной статье The Times of India, вспышка «розового глаза» привела к всплеску продаж офтальмологических лекарств. Продажи выросли почти на 30% в годовом исчислении второй месяц подряд в августе, превысив общий рынок почти в пять раз. Рост отражает массовую заболеваемость конъюнктивитом и осложнениями для глаз за последние несколько месяцев по всей стране
По данным статьи «Мнения пациентов об онлайн-покупках очков», в апреле 2020 года онлайн-покупки контактных линз набирают популярность: 10–20 % пользователей контактных линз в Австралии, США и Великобритании рассматривали или изучали возможность интернет-покупок.

Помимо возможностей розничной торговли, платформы электронного здравоохранения облегчают услуги телемедицины, которые позволяют пациентам консультироваться с офтальмологами удаленно. Виртуальные консультации для плановых осмотров глаз, последующего наблюдения и сортировки при более серьезных заболеваниях могут значительно улучшить доступ к медицинской помощи, особенно для пожилых людей или людей с ограниченными возможностями. Эти платформы повышают вовлеченность пациентов и соблюдение рекомендаций по здоровью глаз и позволяют офтальмологам охватить более широкую базу пациентов без ограничений географических границ. Кроме того, интеграция цифровых медицинских инструментов, таких как мобильные приложения для мониторинга здоровья глаз или лечения хронических заболеваний, может создать бесперебойный опыт для пациентов и способствовать проактивному уходу за глазами, что еще больше стимулирует рост на рынке офтальмологии.

Ограничения/Проблемы

Побочные эффекты и осложнения, связанные с операциями на глазах

Несмотря на значительные достижения в офтальмологическом лечении, некоторые офтальмологические процедуры, особенно хирургические вмешательства, несут в себе риски побочных эффектов и осложнений, таких как инфекция, рубцевание или ухудшение зрения. Эти потенциальные риски могут удерживать пациентов от прохождения определенных видов терапии, особенно тех, которые включают инвазивные процедуры. Страх неблагоприятных последствий, таких как снижение зрения или длительное время восстановления, может привести к нерешительности в обращении за лечением, ограничивая общее принятие определенных методов лечения. Кроме того, осложнения, возникающие в результате операций, могут потребовать дополнительных методов лечения, что еще больше увеличивает расходы на здравоохранение и влияет на доверие пациентов к передовым методам лечения. Это нежелание проходить лечение из-за потенциальных негативных побочных эффектов ограничивает общий рост рынка офтальмологии, замедляя принятие новых технологий и методов лечения.

Например,

В октябре 2024 года, согласно статье, опубликованной Harvard Health, современные операции на глазах, хотя и эффективны при лечении таких заболеваний, как катаракта и глаукома, часто приводят к осложнениям, таким как синдром сухого глаза, характеризующийся ощущением жжения, песка или зуда. Этот побочный эффект может быть неприятным и обескураживающим для пациентов, заставляя некоторых колебаться или избегать операций на глазах. В результате осложнения от лечения сдерживают рост рынка офтальмологии
В июле 2021 года, согласно статье, опубликованной Medical News Today, до 95% людей, перенесших лазерную операцию на глазах, могут испытывать сухость глаз, а 20% сообщают о нарушениях зрения, таких как блики или ореолы. Кроме того, 1 из 50 человек может страдать от нечеткого зрения или синдрома «песков Сахары». Эти побочные эффекты могут отпугнуть пациентов от выбора операции, ограничивая принятие лазерных процедур и выступая сдерживающим фактором для роста рынка офтальмологии

Несмотря на достижения в офтальмологии, некоторые хирургические методы лечения несут в себе такие риски, как инфекция, рубцевание или ухудшение зрения. Эти осложнения могут отпугнуть пациентов от выбора определенных методов лечения, особенно инвазивных процедур. Страх неблагоприятных результатов и дополнительных расходов на лечение может помешать пациентам обратиться за помощью, замедляя принятие новых методов лечения. Это нежелание ограничивает рост мирового рынка офтальмологии.

Ограниченный доступ к специализированной офтальмологической помощи в сельской местности

Несмотря на достижения в инфраструктуре здравоохранения, доступ к специализированной офтальмологической помощи остается ограниченным в сельских и отдаленных районах, что существенно сдерживает потенциал роста рынка офтальмологии в этих регионах. Многие сельские жители по-прежнему сталкиваются с такими проблемами, как нехватка обученных специалистов по уходу за глазами, неадекватные условия и ограниченный доступ к передовым диагностическим и лечебным технологиям. В результате люди в этих районах часто испытывают трудности с получением своевременной диагностики и лечения заболеваний глаз, что приводит к более высокому уровню предотвратимой слепоты и ухудшения зрения. Ограниченная доступность специализированной помощи ограничивает расширение рынка, сокращая внедрение передовых услуг и продуктов по уходу за глазами. Этот барьер для доступа продолжает оставаться основным сдерживающим фактором для общего роста мирового рынка офтальмологии.

Например,

Согласно статье, опубликованной NCBI, в феврале 2023 года многочисленное сельское население Индии сталкивается со значительными неудовлетворенными потребностями в офтальмологической помощи, при этом большинство учреждений и специалистов сосредоточены в городских и полугородских районах. Неравенство в доступе к офтальмологической помощи между сельскими и городскими регионами остается проблемой, ограничивающей доступность лечения. Такое неравномерное распределение ресурсов здравоохранения сдерживает рост мирового рынка офтальмологии, препятствуя широкому доступу к основным услугам в сельских районах
В марте 2024 года, согласно статье, опубликованной Research Gate, «Отсутствие связи и обученного персонала в отдаленных районах затрудняет доступ к непрерывной офтальмологической помощи, даже после успешных офтальмологических лагерей. Пациенты в этих районах испытывают трудности с получением последующего ухода или передового лечения из-за отсутствия надлежащей инфраструктуры. Этот разрыв в предоставлении медицинских услуг ограничивает охват и эффективность программ офтальмологической помощи, выступая сдерживающим фактором для роста мирового рынка офтальмологии»

Доступ к специализированной офтальмологической помощи по-прежнему ограничен в сельской местности, несмотря на улучшение здравоохранения. Нехватка специалистов по офтальмологии, передовых технологий и учреждений препятствует своевременному лечению и диагностике, что приводит к более высоким показателям предотвратимой слепоты. Этот ограниченный доступ препятствует росту мирового рынка офтальмологии, ограничивая внедрение передовых методов лечения и услуг в этих регионах.

Масштаб мирового рынка офтальмологии

Рынок сегментирован на основе продуктов, заболеваний, комплексного обследования глаз, конечного пользователя и канала сбыта. Рост среди этих сегментов поможет вам проанализировать сегменты с незначительным ростом в отраслях и предоставить пользователям ценный обзор рынка и рыночные идеи, которые помогут им принимать стратегические решения для определения основных рыночных приложений.

По продуктам

Устройство
- Хирургическое устройство
  - Хирургические устройства для удаления катаракты
  - Офтальмологические вискоэластичные устройства
    - Устройства для факоэмульсификации
    - Лазеры для хирургического удаления катаракты
    - Инжекторы ИОЛ
  - Витреоретинальные хирургические устройства
    - Аппараты для витрэктомии
    - Витреоретинальные пакеты
    - Фотокоагуляционные лазеры
    - Зонды для витрэктомии
    - Приборы освещения
  - Устройства для рефракционной хирургии
    - Фемтосекундные лазеры
    - Эксимерные лазеры
    - Другие рефракционные хирургические лазеры
  - Хирургические устройства для лечения глаукомы
    - Устройства для дренирования глаукомы
    - Устройства для микроинвазивной хирургии глаукомы
    - Лазерные системы для лечения глаукомы
- Диагностическое устройство
  - Сканеры оптической когерентной томографии (ОКТ)
  - Авторефракторы и кератометры
  - Тонометры
  - Фороптеры
  - Ретиноскопы
  - Офтальмоскопы
  - Щелевые лампы
  - Периметры/анализаторы поля зрения
  - Системы топографии роговицы
  - Фундус-камеры
  - Системы ультразвуковой офтальмологической визуализации
    - Система визуализации A-Scan
    - Система визуализации B-Scan
    - Пахиметры
    - Ультразвуковые биомикроскопы
  - Линзметры
  - Аберрометры волнового фронта
  - Системы оптической биометрии
  - Зеркальные микроскопы
  - Проекторы диаграмм
- Офтальмологические хирургические принадлежности
  - Хирургические инструменты и наборы
  - Глазные пинцеты
  - Офтальмологический шпатель
  - Офтальмологические наконечники и ручки
  - Офтальмологические канюли
  - Офтальмологические ножницы
  - Другие хирургические принадлежности
- Офтальмологические микроскопы
Наркотики, побочные продукты
- Препараты против VEGF
  - Ранибизумаб
  - Бевацизумаб
- Препараты для лечения заболеваний сетчатки
- Препараты против глаукомы
  - Аналоги простагландинов
    - Латанопрост
    - Биматопрост
    - Травопрост
    - Тафлупрост
    - Латанопростен
  - БЕТА-адреноблокаторы
    - Тимолал малеат
    - Бетаксолол
  - Альфа-адренергические агонисты
    - Адреналин
    - Депивеприн
  - Миотики
    - Пилокарпин
    - Эзерин
- Препараты от сухости глаз
- Противовоспалительные препараты
  - Стероидные противовоспалительные препараты
  - Нестероидные противовоспалительные препараты
- Лекарства от аллергического конъюнктивита
- Другие
Наркотики, по типу наркотиков
- Фирменный
- Общий
Лекарственные препараты, отпускаемые по рецепту
- Рецепт
- Без рецепта
Лекарственные средства по способу введения
- Актуальный
  - Глазные капли
  - Раствор для глаз
  - Крема и мази
  - Гель
  - Другие
- Местный глазной
  - Интравитреальный
  - Субконъюнктивальный
  - Ретробульбарный
  - Внутрикамерный
- Инъекционные препараты
  - Внутримышечно
  - Внутривенно
  - Другие
- Оральный
  - Планшет
  - Капсулы
  - Другие
- Другие
Другие
- Средства по уходу за зрением
  - Очки
  - Контактные линзы
    - Мягкие контактные линзы
    - Гибридные контактные линзы
    - Жесткие газопроницаемые линзы
- Другие

По болезням

катаракта
Нарушения рефракции
Глаукома
Возрастная макулярная дегенерация
Воспалительные заболевания
Другие

Комплексное обследование глаз

Рефракция
- Автоматические рефрактометры
- Набор пробных линз
- Циклоплегические препараты
- Пробная рамка
- Самоосвещающийся/зеркальный ретиноскоп
- Цилиндр Джексона Креста
Тест на остроту зрения
- Диаграмма Снеллена
- Таблицы ближнего зрения
Внутриглазное давление
- Тонометры (Goldmann, Tono-Pen, Perkins, Shiotz)
- Другие
Исследование переднего сегмента и зрачка
- Биомикроскоп с щелевой лампой
- Фонарик
Тест поля зрения
- Central 30-2 Полнопороговый анализатор поля зрения Humphrey
- Периметр удвоения частоты
- Кинетический периметр Гольдмана
Тест на цветовое зрение
Другие

Конечным пользователем

Клиники
Больницы
Домашнее здравоохранение
Другие

По каналу распространения

Розничные продажи
- Розничные магазины
- Больничная аптека
- Интернет-аптека
Прямой тендер
Другие

Get Exclusive Sample PDF of this Report Here

Региональный анализ мирового рынка офтальмологии

Рынок сегментирован по видам продукции, заболеваниям, комплексному обследованию глаз, конечному пользователю и каналу сбыта.

Страны, охваченные этим рынком: США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Испания, Швейцария, Россия, Бельгия, Нидерланды, Турция, остальные страны Европы, Китай, Индия, Япония, Южная Корея, Австралия, Индонезия, Таиланд, Малайзия, Филиппины, Сингапур, остальные страны Азиатско-Тихоокеанского региона, Бразилия, Аргентина, остальные страны Южной Америки, Южная Африка, Саудовская Аравия, ОАЭ, Египет, Израиль и остальные страны Ближнего Востока и Африки.

Ожидается, что Северная Америка будет доминировать на рынке из-за развитой инфраструктуры здравоохранения, высоких расходов на здравоохранение и большого стареющего населения с растущей распространенностью заболеваний глаз. Кроме того, значительные инвестиции в исследования, разработки и внедрение передовых технологий способствуют лидерству на рынке в регионе.

Ожидается, что Европа будет самым быстрорастущим регионом из-за большого стареющего населения региона и растущей осведомленности о здоровье глаз. Растущий доступ к здравоохранению, экономический рост и достижения в области медицинских технологий еще больше стимулируют спрос на офтальмологическое лечение в регионе.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции и анализ пяти сил Портера, тематические исследования, являются некоторыми из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и внутренних брендов, влияние внутренних тарифов и торговых путей.

Get Exclusive Sample PDF of this Report Here

Доля на мировом рынке офтальмологии

Конкурентная среда рынка содержит сведения о конкурентах. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта, доминировании приложений. Приведенные выше данные касаются только фокуса компаний на рынке.

Лидерами мирового рынка офтальмологии являются:

Alcon (Швейцария)
Bausch + Lomb (Канада)
Carl Zeiss Meditec(Германия)
Корпорация Hoya (Япония)
Johnson & Johnson Services, Inc. (США)
Essilor International (Франция)
Корпорация Topcon (Япония)
Корпорация Glaukos (США)
Группа Haag-Streit (Швейцария)
Nidek Co., Ltd (США)
Staar Surgical (Калифорния)
Ziemer Ophthalmic Systems Ag (Швейцария)
Компании Cooper (США)
Lumenis Be Ltd. (Израиль)
Reichert Inc. (Нью-Йорк)
Bayer Ag (Германия)
Novartis Ag (Швейцария)
Abbvie Inc. (США)
F. Hoffmann-La Roche Ltd.(Швейцария)
Домпе (Италия)
Santen Pharmaceutical Co.(Япония), Ltd.
среди прочего

Последние разработки на мировом рынке офтальмологии

В октябре 2024 г. на встрече AAO 2024 компания Alcon представила свои инновации, включая Voyager DSLT для лечения глаукомы, портативные системы подачи газа UNIFEYE и UNIPEXY, а также основные данные для AR-15512, лечения синдрома сухого глаза. Эти достижения направлены на улучшение результатов и хирургической эффективности
В сентябре 2024 года EssilorLuxottica и Meta расширили свое партнерство, заключив долгосрочное соглашение о разработке многопоколенческих интеллектуальных очков. Опираясь на успех очков Ray-Ban Meta, компании намерены вместе формировать будущее носимых технологий
В ОКТЯБРЕ 2024 ГОДА компания Bausch + Lomb представила новые научные данные и образовательные мероприятия на встрече AAO 2024 в Чикаго. Среди основных моментов были исследования enVista Envy IOL, TENEO Excimer Laser, VYZULTA и презентации Blink Nutritears, MIEBO и Xiidra
В апреле 2024 года AbbVie завершила приобретение Cerevel Therapeutics, расширив свой портфель в области нейробиологии. Приобретение включает перспективные клинические активы Cerevel, такие как Emraclidine для лечения шизофрении и Tavapadon для лечения болезни Паркинсона, что укрепляет позиции AbbVie в области неврологии и психиатрии
В сентябре 2023 года Novartis завершила продажу своих офтальмологических активов «front of eye» компании Bausch + Lomb на сумму до 2,5 млрд долларов США, включая 1,75 млрд долларов США в виде аванса и потенциальных поэтапных платежей. Сделка включала Xiidra®, SAF312, AcuStream и OJL332. Novartis продвинула свою стратегию, сосредоточившись на приоритетных терапевтических областях для будущего роста

SKU-69591

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Интерактивная панель анализа данных
Панель анализа компании для возможностей с высоким потенциалом роста
Доступ аналитика-исследователя для настройки и запросов
Анализ конкурентов с помощью интерактивной панели
Последние новости, обновления и анализ тенденций
Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов

Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL OPHTHALMOLOGY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 GLOBAL OPHTHALMOLOGY MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF EYE DISEASES

6.1.2 FOCUS ON PREVENTATIVE EYE CARE

6.1.3 GOVERNMENT EYECARE INITIATIVES

6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES

6.2 RESTRAINTS

6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES

6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS

6.3 OPPORTUNITIES

6.3.1 RISE IN THE AGING POPULATION

6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS

6.3.3 ENHANCED PATIENT EDUCATION

6.4 CHALLENGES

6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS

6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS

7 GLOBAL OPHTHALMOLOGY MARKETGLOBAL OPHTHALMOLOGY MARKET, BY PRODUCTS

7.1 OVERVIEW

7.2 DEVICE

7.2.1 SURGICAL DEVICE

7.2.1.1 CATARACT SURGICAL DEVICES

7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES

7.2.1.2.1 PHACOEMULSIFICATION DEVICES

7.2.1.2.2 CATARACT SURGICAL LASERS

7.2.1.2.3 IOL INJECTORS

7.2.1.3 VITREORETINAL SURGICAL DEVICES

7.2.1.3.1 VITREORETINAL PACKS

7.2.1.3.2 VITRECTOMY MACHINES

7.2.1.3.3 VITRECTOMY PROBES

7.2.1.3.4 PHOTOCOAGULATION LASERS

7.2.1.3.5 ILLUMINATION DEVICES

7.2.1.4 REFRACTIVE SURGICAL DEVICES

7.2.1.4.1 FEMTOSECOND LASERS

7.2.1.4.2 EXCIMER LASERS

7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS

7.2.1.5 GLAUCOMA SURGICAL DEVICES

7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES

7.2.1.5.2 GLAUCOMA LASER SYSTEMS

7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES

7.2.2 DIAGNOSTIC DEVICE

7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS

7.2.2.2 AUTOREFRACTORS & KERATOMETERS

7.2.2.3 TONOMETERS

7.2.2.4 PHOROPTERS

7.2.2.5 RETINOSCOPES

7.2.2.6 OPHTHALMOSCOPES

7.2.2.7 SLIT LAMPS

7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS

7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS

7.2.2.10 FUNDUS CAMERAS

7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

7.2.2.11.1 A- SCAN IMAGING SYSTEM

7.2.2.11.2 B-SCAN IMAGING SYSTEM

7.2.2.11.3 PACHYMETERS

7.2.2.11.4 ULTRASOUND BIOMICROSCOPES

7.2.2.12 LENSMETERS

7.2.2.13 WAVEFRONT ABERROMETERS

7.2.2.14 OPTICAL BIOMETRY SYSTEMS

7.2.2.15 SPECULAR MICROSCOPES

7.2.2.16 CHART PROJECTORS

7.2.3 OPHTHALMIC SURGICAL ACCESSORIES

7.2.3.1 SURGICAL INSTRUMENTS & KITS

7.2.3.2 OPHTHALMIC FORCEPS

7.2.3.3 OPHTHALMIC SPATULA

7.2.3.4 OPHTHALMIC TIPS AND HANDLES

7.2.3.5 OPHTHALMIC CANNULAS

7.2.3.6 OPHTHALMIC SCISSORS

7.2.3.7 OTHERS SURGICAL ACCESSORIES

7.2.4 OPHTHALMIC MICROSCOPES

7.3 DRUGS

7.3.1 ANTI-VEGF DRUGS

7.3.1.1 RANIBIZUMAB

7.3.1.2 BEVACIZUMAB

7.3.2 ANTI-GLAUCOMA DRUGS

7.3.2.1 PROSTAGLANDIN ANALOGS

7.3.2.1.1 LATANOPROST

7.3.2.1.2 BIMATOPROST

7.3.2.1.3 TRAVOPROST

7.3.2.1.4 TAFLUPROST

7.3.2.1.5 LATANOPROSTENE

7.3.2.2 BETA ADRENERGIC ANTAGONISTS

7.3.2.2.1 TIMOLAL MALEATE

7.3.2.2.2 BETAXOLOL

7.3.2.3 ALPHA ADRENERGIC AGONISTS

7.3.2.3.1 EPINEPHRINE

7.3.2.3.2 DEPIVEPRINE

7.3.2.4 MIOTICS

7.3.2.4.1 PILOCARPINE

7.3.2.4.2 ESERINE

7.3.3 ANTI-INFLAMMATION DRUGS

7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.4 RETINAL DISORDER DRUGS

7.3.5 DRY EYE DRUGS

7.3.6 ALLERGIC CONJUCTIVITIS DRUGS

7.3.7 OTHERS

7.3.7.1 BRANDED

7.3.7.2 GENERIC

7.3.7.3 PRESCRIPTION

7.3.7.4 OVER THE COUNTER

7.3.7.5 TOPICAL

7.3.7.6 LOCAL OCULAR

7.3.7.7 INJECTABLES

7.3.7.8 ORAL

7.3.7.9 OTHERS

7.3.7.10 EYE DROPS

7.3.7.11 EYE SOLUTION

7.3.7.12 CREAM & OINTMENTS

7.3.7.13 GEL

7.3.7.14 OTHERS

7.3.7.15 INTRAVITREAL

7.3.7.16 SUBCONJUNCTIVAL

7.3.7.17 RETROBULBAR

7.3.7.18 INTRACAMERAL

7.3.7.19 INTRAMUSCULAR

7.3.7.20 INTRAVENOUS

7.3.7.21 OTHERS

7.3.7.22 TABLET

7.3.7.23 CAPSULES

7.3.7.24 OTHERS

7.4 OTHERS

7.4.1 VISION CARE PRODUCTS

7.4.1.1 SPECTACLES

7.4.1.2 CONTACT LENSES

7.4.1.2.1 SOFT CONTACT LENSES

7.4.1.2.2 HYBRID CONTACT LENSES

7.4.1.2.3 RIGID GAS PERMEABLE LENSES

7.4.2 OTHERS

8 GLOBAL OPHTHALMOLOGY MARKET, BY DISEASES

8.1 OVERVIEW

8.2 CATARACT

8.3 REFRACTIVE DISORDERS

8.4 GLAUCOMA

8.5 AGE-RELATED MACULAR DEGENERATION

8.6 INFLAMMATORY DISEASES

8.7 OTHERS

9 GLOBAL OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION

9.1 OVERVIEW

9.2 REFRACTION

9.2.1 AUTOMATED REFRACTOMETERS

9.2.2 SET OF TRIAL LENSES

9.2.3 CYCLOPLEGIC DRUGS

9.2.4 TRIAL FRAME

9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE

9.2.6 JACKSON CROSS CYLINDER

9.3 VISUAL ACUITY TEST

9.3.1 SNELLEN'S CHART

9.3.2 NEAR VISION CHARTS

9.4 INTRAOCULAR PRESSURE

9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)

9.4.2 OTHERS

9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION

9.5.1 SLIT LAMP BIOMICROSCOPE

9.5.2 TORCH LIGHT

9.6 VISUAL FIELDS TEST

9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER

9.6.2 FREQUENCY DOUBLING PERIMETER

9.6.3 GOLDMANN KINETIC PERIMETER

9.7 COLOR VISION TEST

9.8 OTHERS

10 GLOBAL OPHTHALMOLOGY MARKET, BY END USER

10.1 OVERVIEW

10.2 CLINICS

10.3 HOSPITALS

10.4 HOME HEALTHCARE

10.5 OTHERS

11 GLOBAL OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL SHOPS

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

11.4 OTHERS

12 GLOBAL OPHTHALMOLOGY MARKET BY GEOGRAPHY

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

12.2 EUROPE

12.2.1 GERMANY

12.2.2 FRANCE

12.2.3 U.K.

12.2.4 ITALY

12.2.5 SPAIN

12.2.6 SWITZERLAND

12.2.7 RUSSIA

12.2.8 BELGIUM

12.2.9 NETHERLANDS

12.2.10 TURKEY

12.2.11 REST OF EUROPE

12.3 ASIA-PACIFIC

12.3.1 CHINA

12.3.2 INDIA

12.3.3 JAPAN

12.3.4 SOUTH KOREA

12.3.5 AUSTRALIA

12.3.6 INDONESIA

12.3.7 THAILAND

12.3.8 MALAYSIA

12.3.9 PHILIPPINES

12.3.10 SINGAPORE

12.3.11 REST OF ASIA-PACIFIC

12.4 SOUTH AMERICA

12.4.1 BRAZIL

12.4.2 ARGENTINA

12.4.3 REST OF SOUTH AMERICA

12.5 MIDDLE EAST AND AFRICA

12.5.1 SOUTH AFRICA

12.5.2 SAUDI ARABIA

12.5.3 U.A.E

12.5.4 EGYPT

12.5.5 ISRAEL

12.5.6 REST OF MIDDLE EAST AND AFRICA

13 GLOBAL OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3 COMPANY SHARE ANALYSIS: EUROPE

13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 ALCON

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 JOHNSON & JOHNSON SERVICES, INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ESSILOR LUXOTTICA

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 NOVARTIS AG

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 BAUSCH + LOMB

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 REVENUE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ABBVIE INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BAYER AG

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 CARL ZEISS MEDITEC AG

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENT

15.9 COOPER COMPANIES

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.1 DOMPÉ

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 F. HOFFMANN-LA ROCHE LTD

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 GLAUKOS CORPORATION

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT

15.13 HAAG-STREIT

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 HOYA CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENT

15.15 LUMENIS BE LTD.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 NIDEK CO.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 REICHERT, INC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 SANTEN PHARMACEUTICAL CO.

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENT

15.19 STAAR SURGICAL

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENT

15.2 TOPCON CORPORATION

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENT

15.21 ZIEMER OPHTHALMIC SYSTEMS AG

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

Список таблиц

TABLE 1 GLOBAL OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 2 GLOBAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 3 GLOBAL SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 4 GLOBAL OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 5 GLOBAL VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 6 GLOBAL REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 7 GLOBAL GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 8 GLOBAL DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 9 GLOBAL OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 10 GLOBAL OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 11 GLOBAL DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 12 GLOBAL ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 13 GLOBAL ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 14 GLOBAL PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 15 GLOBAL BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 16 GLOBAL ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 17 GLOBAL MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 18 GLOBAL ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 19 GLOBAL DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 20 GLOBAL DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 21 GLOBAL DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 22 GLOBAL TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 23 GLOBAL LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 24 GLOBAL INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 25 GLOBAL ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 26 GLOBAL OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 27 GLOBAL VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 28 GLOBAL CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 29 GLOBAL OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 30 GLOBAL CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 31 GLOBAL REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 32 GLOBAL GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 33 GLOBAL AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 34 GLOBAL INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 35 GLOBAL OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 36 GLOBAL OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 37 GLOBAL REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 38 GLOBAL REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 39 GLOBAL VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 40 GLOBAL VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 41 GLOBAL INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 42 GLOBAL INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 43 GLOBAL ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 44 GLOBAL ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 45 GLOBAL VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 46 GLOBAL VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 47 GLOBAL COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 48 GLOBAL OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 49 GLOBAL OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 50 GLOBAL CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 51 GLOBAL HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 52 GLOBAL HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 53 GLOBAL OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 54 GLOBAL OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 55 GLOBAL RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 56 GLOBAL RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 57 GLOBAL DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 58 GLOBAL OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 59 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 60 NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 61 NORTH AMERICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 62 NORTH AMERICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 63 NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 64 NORTH AMERICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 65 NORTH AMERICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 66 NORTH AMERICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 67 NORTH AMERICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 68 NORTH AMERICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 69 NORTH AMERICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 70 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 71 NORTH AMERICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 72 NORTH AMERICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 73 NORTH AMERICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 74 NORTH AMERICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 75 NORTH AMERICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 76 NORTH AMERICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 77 NORTH AMERICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 78 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 79 NORTH AMERICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 80 NORTH AMERICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 81 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 82 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 83 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 84 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 85 NORTH AMERICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 86 NORTH AMERICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 87 NORTH AMERICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 88 NORTH AMERICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 89 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 90 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 91 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 92 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 93 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 94 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 95 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 96 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 97 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 98 U.S. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 99 U.S. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 100 U.S. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 101 U.S. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 102 U.S. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 103 U.S. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 104 U.S. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 105 U.S. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 106 U.S. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 107 U.S. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 108 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 109 U.S. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 110 U.S. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 111 U.S. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 112 U.S. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 113 U.S. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 114 U.S. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 115 U.S. ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 116 U.S. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 117 U.S. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 118 U.S. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 119 U.S. OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 120 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 121 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 122 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 123 U.S. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 124 U.S. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 125 U.S. INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 126 U.S. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 127 U.S. OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 128 U.S. REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 129 U.S. VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 130 U.S. INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 131 U.S. ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 132 U.S. VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 133 U.S. OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 134 U.S. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 135 U.S. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 136 CANADA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 137 CANADA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 138 CANADA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 139 CANADA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 140 CANADA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 141 CANADA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 142 CANADA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 143 CANADA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 144 CANADA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 145 CANADA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 146 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 147 CANADA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 148 CANADA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 149 CANADA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 150 CANADA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 151 CANADA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 152 CANADA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 153 CANADA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 154 CANADA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 155 CANADA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 156 CANADA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 157 CANADA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 158 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 159 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 160 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 161 CANADA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 162 CANADA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 163 CANADA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 164 CANADA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 165 CANADA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 166 CANADA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 167 CANADA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 168 CANADA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 169 CANADA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 170 CANADA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 171 CANADA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 172 CANADA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 173 CANADA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 174 MEXICO OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 175 MEXICO DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 176 MEXICO SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 177 MEXICO OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 178 MEXICO VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 179 MEXICO REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 180 MEXICO GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 181 MEXICO DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 182 MEXICO OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 183 MEXICO OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 184 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 185 MEXICO ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 186 MEXICO ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 187 MEXICO PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 188 MEXICO BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 189 MEXICO ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 190 MEXICO MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 191 MEXICO ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 192 MEXICO OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 193 MEXICO VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 194 MEXICO CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 195 MEXICO OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 196 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 197 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 198 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 199 MEXICO TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 200 MEXICO LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 201 MEXICO INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 202 MEXICO ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 203 MEXICO OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 204 MEXICO REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 205 MEXICO VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 206 MEXICO INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 207 MEXICO ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 208 MEXICO VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 209 MEXICO OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 210 MEXICO OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 211 MEXICO RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 212 EUROPE OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 213 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 214 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 215 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 216 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 217 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 218 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 219 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 220 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 221 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 222 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 223 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 224 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 225 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 226 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 227 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 228 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 229 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 230 EUROPE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 231 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 232 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 233 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 234 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 235 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 236 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 237 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 238 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 239 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 240 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 241 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 242 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 243 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 244 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 245 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 246 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 247 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 248 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 249 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 250 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 251 GERMANY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 252 GERMANY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 253 GERMANY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 254 GERMANY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 255 GERMANY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 256 GERMANY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 257 GERMANY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 258 GERMANY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 259 GERMANY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 260 GERMANY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 261 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 262 GERMANY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 263 GERMANY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 264 GERMANY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 265 GERMANY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 266 GERMANY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 267 GERMANY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 268 GERMANY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 269 GERMANY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 270 GERMANY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 271 GERMANY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 272 GERMANY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 273 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 274 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 275 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 276 GERMANY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 277 GERMANY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 278 GERMANY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 279 GERMANY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 280 GERMANY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 281 GERMANY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 282 GERMANY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 283 GERMANY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 284 GERMANY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 285 GERMANY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 286 GERMANY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 287 GERMANY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 288 GERMANY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 289 FRANCE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 290 FRANCE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 291 FRANCE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 292 FRANCE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 293 FRANCE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 294 FRANCE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 295 FRANCE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 296 FRANCE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 297 FRANCE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 298 FRANCE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 299 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 300 FRANCE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 301 FRANCE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 302 FRANCE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 303 FRANCE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 304 FRANCE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 305 FRANCE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 306 FRANCE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 307 FRANCE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 308 FRANCE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 309 FRANCE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 310 FRANCE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 311 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 312 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 313 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 314 FRANCE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 315 FRANCE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 316 FRANCE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 317 FRANCE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 318 FRANCE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 319 FRANCE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 320 FRANCE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 321 FRANCE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 322 FRANCE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 323 FRANCE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 324 FRANCE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 325 FRANCE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 326 FRANCE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 327 U.K. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 328 U.K. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 329 U.K. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 330 U.K. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 331 U.K. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 332 U.K. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 333 U.K. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 334 U.K. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 335 U.K. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 336 U.K. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 337 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 338 U.K. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 339 U.K. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 340 U.K. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 341 U.K. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 342 U.K. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 343 U.K. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 344 U.K. ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 345 U.K. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 346 U.K. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 347 U.K. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 348 U.K. OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 349 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 350 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 351 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 352 U.K. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 353 U.K. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 354 U.K. INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 355 U.K. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 356 U.K. OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 357 U.K. REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 358 U.K. VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 359 U.K. INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 360 U.K. ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 361 U.K. VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 362 U.K. OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 363 U.K. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 364 U.K. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 365 ITALY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 366 ITALY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 367 ITALY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 368 ITALY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 369 ITALY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 370 ITALY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 371 ITALY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 372 ITALY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 373 ITALY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 374 ITALY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 375 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 376 ITALY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 377 ITALY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 378 ITALY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 379 ITALY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 380 ITALY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 381 ITALY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 382 ITALY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 383 ITALY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 384 ITALY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 385 ITALY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 386 ITALY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 387 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 388 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 389 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 390 ITALY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 391 ITALY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 392 ITALY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 393 ITALY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 394 ITALY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 395 ITALY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 396 ITALY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 397 ITALY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 398 ITALY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 399 ITALY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 400 ITALY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 401 ITALY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 402 ITALY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 403 SPAIN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 404 SPAIN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 405 SPAIN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 406 SPAIN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 407 SPAIN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 408 SPAIN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 409 SPAIN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 410 SPAIN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 411 SPAIN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 412 SPAIN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 413 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 414 SPAIN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 415 SPAIN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 416 SPAIN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 417 SPAIN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 418 SPAIN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 419 SPAIN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 420 SPAIN ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 421 SPAIN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 422 SPAIN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 423 SPAIN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 424 SPAIN OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 425 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 426 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 427 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 428 SPAIN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 429 SPAIN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 430 SPAIN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 431 SPAIN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 432 SPAIN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 433 SPAIN REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 434 SPAIN VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 435 SPAIN INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 436 SPAIN ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 437 SPAIN VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 438 SPAIN OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 439 SPAIN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 440 SPAIN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 441 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 442 SWITZERLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 443 SWITZERLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 444 SWITZERLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 445 SWITZERLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 446 SWITZERLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 447 SWITZERLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 448 SWITZERLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 449 SWITZERLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 450 SWITZERLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 451 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 452 SWITZERLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 453 SWITZERLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 454 SWITZERLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 455 SWITZERLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 456 SWITZERLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 457 SWITZERLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 458 SWITZERLAND ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 459 SWITZERLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 460 SWITZERLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 461 SWITZERLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 462 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 463 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 464 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 465 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 466 SWITZERLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 467 SWITZERLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 468 SWITZERLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 469 SWITZERLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 470 SWITZERLAND OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 471 SWITZERLAND REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 472 SWITZERLAND VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 473 SWITZERLAND INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 474 SWITZERLAND ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 475 SWITZERLAND VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 476 SWITZERLAND OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 477 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 478 SWITZERLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 479 RUSSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 480 RUSSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 481 RUSSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 482 RUSSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 483 RUSSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 484 RUSSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 485 RUSSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 486 RUSSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 487 RUSSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 488 RUSSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 489 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 490 RUSSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 491 RUSSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 492 RUSSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 493 RUSSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 494 RUSSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 495 RUSSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 496 RUSSIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 497 RUSSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 498 RUSSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 499 RUSSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 500 RUSSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 501 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 502 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 503 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 504 RUSSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 505 RUSSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 506 RUSSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 507 RUSSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 508 RUSSIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 509 RUSSIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 510 RUSSIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 511 RUSSIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 512 RUSSIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 513 RUSSIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 514 RUSSIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 515 RUSSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 516 RUSSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 517 BELGIUM OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 518 BELGIUM DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 519 BELGIUM SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 520 BELGIUM OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 521 BELGIUM VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 522 BELGIUM REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 523 BELGIUM GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 524 BELGIUM DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 525 BELGIUM OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 526 BELGIUM OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 527 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 528 BELGIUM ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 529 BELGIUM ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 530 BELGIUM PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 531 BELGIUM BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 532 BELGIUM ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 533 BELGIUM MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 534 BELGIUM ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 535 BELGIUM OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 536 BELGIUM VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 537 BELGIUM CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 538 BELGIUM OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 539 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 540 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 541 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 542 BELGIUM TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 543 BELGIUM LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 544 BELGIUM INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 545 BELGIUM ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 546 BELGIUM OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 547 BELGIUM REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 548 BELGIUM VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 549 BELGIUM INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 550 BELGIUM ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 551 BELGIUM VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 552 BELGIUM OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 553 BELGIUM OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 554 BELGIUM RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 555 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 556 NETHERLANDS DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 557 NETHERLANDS SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 558 NETHERLANDS OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 559 NETHERLANDS VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 560 NETHERLANDS REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 561 NETHERLANDS GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 562 NETHERLANDS DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 563 NETHERLANDS OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 564 NETHERLANDS OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 565 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 566 NETHERLANDS ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 567 NETHERLANDS ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 568 NETHERLANDS PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 569 NETHERLANDS BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 570 NETHERLANDS ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 571 NETHERLANDS MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 572 NETHERLANDS ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 573 NETHERLANDS OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 574 NETHERLANDS VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 575 NETHERLANDS CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 576 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 577 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 578 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 579 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 580 NETHERLANDS TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 581 NETHERLANDS LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 582 NETHERLANDS INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 583 NETHERLANDS ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 584 NETHERLANDS OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 585 NETHERLANDS REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 586 NETHERLANDS VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 587 NETHERLANDS INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 588 NETHERLANDS ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 589 NETHERLANDS VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 590 NETHERLANDS OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 591 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 592 NETHERLANDS RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 593 TURKEY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 594 TURKEY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 595 TURKEY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 596 TURKEY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 597 TURKEY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 598 TURKEY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 599 TURKEY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 600 TURKEY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 601 TURKEY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 602 TURKEY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 603 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 604 TURKEY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 605 TURKEY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 606 TURKEY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 607 TURKEY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 608 TURKEY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 609 TURKEY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 610 TURKEY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 611 TURKEY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 612 TURKEY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 613 TURKEY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 614 TURKEY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 615 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 616 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 617 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 618 TURKEY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 619 TURKEY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 620 TURKEY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 621 TURKEY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 622 TURKEY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 623 TURKEY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 624 TURKEY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 625 TURKEY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 626 TURKEY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 627 TURKEY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 628 TURKEY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 629 TURKEY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 630 TURKEY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 631 REST OF EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 632 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 633 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 634 ASIA-PACIFIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 635 ASIA-PACIFIC SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 636 ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 637 ASIA-PACIFIC VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 638 ASIA-PACIFIC REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 639 ASIA-PACIFIC GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 640 ASIA-PACIFIC DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 641 ASIA-PACIFIC OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 642 ASIA-PACIFIC OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 643 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 644 ASIA-PACIFIC ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 645 ASIA-PACIFIC ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 646 ASIA-PACIFIC PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 647 ASIA-PACIFIC BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 648 ASIA-PACIFIC ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 649 ASIA-PACIFIC MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 650 ASIA-PACIFIC ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 651 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 652 ASIA-PACIFIC VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 653 ASIA-PACIFIC CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 654 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 655 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 656 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 657 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 658 ASIA-PACIFIC TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 659 ASIA-PACIFIC LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 660 ASIA-PACIFIC INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 661 ASIA-PACIFIC ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 662 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 663 ASIA-PACIFIC REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 664 ASIA-PACIFIC VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 665 ASIA-PACIFIC INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 666 ASIA-PACIFIC ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 667 ASIA-PACIFIC VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 668 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 669 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 670 ASIA-PACIFIC RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 671 CHINA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 672 CHINA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 673 CHINA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 674 CHINA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 675 CHINA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 676 CHINA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 677 CHINA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 678 CHINA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 679 CHINA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 680 CHINA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 681 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 682 CHINA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 683 CHINA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 684 CHINA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 685 CHINA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 686 CHINA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 687 CHINA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 688 CHINA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 689 CHINA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 690 CHINA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 691 CHINA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 692 CHINA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 693 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 694 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 695 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 696 CHINA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 697 CHINA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 698 CHINA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 699 CHINA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 700 CHINA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 701 CHINA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 702 CHINA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 703 CHINA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 704 CHINA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 705 CHINA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 706 CHINA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 707 CHINA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 708 CHINA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 709 INDIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 710 INDIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 711 INDIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 712 INDIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 713 INDIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 714 INDIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 715 INDIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 716 INDIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 717 INDIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 718 INDIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 719 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 720 INDIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 721 INDIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 722 INDIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 723 INDIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 724 INDIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 725 INDIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 726 INDIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 727 INDIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 728 INDIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 729 INDIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 730 INDIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 731 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 732 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 733 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 734 INDIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 735 INDIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 736 INDIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 737 INDIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 738 INDIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 739 INDIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 740 INDIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 741 INDIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 742 INDIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 743 INDIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 744 INDIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 745 INDIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 746 INDIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 747 JAPAN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 748 JAPAN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 749 JAPAN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 750 JAPAN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 751 JAPAN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 752 JAPAN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 753 JAPAN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 754 JAPAN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 755 JAPAN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 756 JAPAN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 757 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 758 JAPAN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 759 JAPAN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 760 JAPAN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 761 JAPAN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 762 JAPAN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 763 JAPAN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 764 JAPAN ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 765 JAPAN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 766 JAPAN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 767 JAPAN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 768 JAPAN OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 769 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 770 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 771 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 772 JAPAN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 773 JAPAN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 774 JAPAN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 775 JAPAN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 776 JAPAN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 777 JAPAN REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 778 JAPAN VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 779 JAPAN INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 780 JAPAN ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 781 JAPAN VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 782 JAPAN OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 783 JAPAN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 784 JAPAN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 785 SOUTH KOREA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 786 SOUTH KOREA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 787 SOUTH KOREA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 788 SOUTH KOREA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 789 SOUTH KOREA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 790 SOUTH KOREA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 791 SOUTH KOREA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 792 SOUTH KOREA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 793 SOUTH KOREA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 794 SOUTH KOREA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 795 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 796 SOUTH KOREA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 797 SOUTH KOREA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 798 SOUTH KOREA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 799 SOUTH KOREA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 800 SOUTH KOREA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 801 SOUTH KOREA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 802 SOUTH KOREA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 803 SOUTH KOREA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 804 SOUTH KOREA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 805 SOUTH KOREA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 806 SOUTH KOREA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 807 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 808 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 809 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 810 SOUTH KOREA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 811 SOUTH KOREA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 812 SOUTH KOREA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 813 SOUTH KOREA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 814 SOUTH KOREA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 815 SOUTH KOREA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 816 SOUTH KOREA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 817 SOUTH KOREA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 818 SOUTH KOREA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 819 SOUTH KOREA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 820 SOUTH KOREA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 821 SOUTH KOREA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 822 SOUTH KOREA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 823 AUSTRALIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 824 AUSTRALIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 825 AUSTRALIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 826 AUSTRALIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 827 AUSTRALIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 828 AUSTRALIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 829 AUSTRALIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 830 AUSTRALIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 831 AUSTRALIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 832 AUSTRALIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 833 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 834 AUSTRALIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 835 AUSTRALIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 836 AUSTRALIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 837 AUSTRALIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 838 AUSTRALIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 839 AUSTRALIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 840 AUSTRALIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 841 AUSTRALIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 842 AUSTRALIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 843 AUSTRALIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 844 AUSTRALIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 845 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 846 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 847 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 848 AUSTRALIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 849 AUSTRALIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 850 AUSTRALIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 851 AUSTRALIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 852 AUSTRALIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 853 AUSTRALIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 854 AUSTRALIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 855 AUSTRALIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 856 AUSTRALIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 857 AUSTRALIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 858 AUSTRALIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 859 AUSTRALIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 860 AUSTRALIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 861 INDONESIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 862 INDONESIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 863 INDONESIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 864 INDONESIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 865 INDONESIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 866 INDONESIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 867 INDONESIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 868 INDONESIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 869 INDONESIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 870 INDONESIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 871 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 872 INDONESIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 873 INDONESIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 874 INDONESIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 875 INDONESIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 876 INDONESIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 877 INDONESIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 878 INDONESIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 879 INDONESIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 880 INDONESIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 881 INDONESIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 882 INDONESIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 883 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 884 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 885 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 886 INDONESIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 887 INDONESIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 888 INDONESIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 889 INDONESIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 890 INDONESIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 891 INDONESIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 892 INDONESIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 893 INDONESIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 894 INDONESIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 895 INDONESIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 896 INDONESIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 897 INDONESIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 898 INDONESIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 899 THAILAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 900 THAILAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 901 THAILAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 902 THAILAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 903 THAILAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 904 THAILAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 905 THAILAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 906 THAILAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 907 THAILAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 908 THAILAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 909 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 910 THAILAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 911 THAILAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 912 THAILAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 913 THAILAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 914 THAILAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 915 THAILAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 916 THAILAND ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 917 THAILAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 918 THAILAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 919 THAILAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 920 THAILAND OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 921 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 922 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 923 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 924 THAILAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 925 THAILAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 926 THAILAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 927 THAILAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 928 THAILAND OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 929 THAILAND REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 930 THAILAND VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 931 THAILAND INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 932 THAILAND ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 933 THAILAND VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 934 THAILAND OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 935 THAILAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 936 THAILAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 937 MALAYSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 938 MALAYSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 939 MALAYSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 940 MALAYSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 941 MALAYSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 942 MALAYSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 943 MALAYSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 944 MALAYSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 945 MALAYSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 946 MALAYSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 947 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 948 MALAYSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 949 MALAYSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 950 MALAYSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 951 MALAYSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 952 MALAYSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 953 MALAYSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 954 MALAYSIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 955 MALAYSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 956 MALAYSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 957 MALAYSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 958 MALAYSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 959 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 960 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 961 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 962 MALAYSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 963 MALAYSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 964 MALAYSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 965 MALAYSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 966 MALAYSIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 967 MALAYSIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 968 MALAYSIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 969 MALAYSIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 970 MALAYSIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 971 MALAYSIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 972 MALAYSIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 973 MALAYSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 974 MALAYSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 975 PHILIPPINES OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 976 PHILIPPINES DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 977 PHILIPPINES SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 978 PHILIPPINES OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 979 PHILIPPINES VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 980 PHILIPPINES REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 981 PHILIPPINES GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 982 PHILIPPINES DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 983 PHILIPPINES OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 984 PHILIPPINES OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 985 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 986 PHILIPPINES ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 987 PHILIPPINES ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 988 PHILIPPINES PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 989 PHILIPPINES BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 990 PHILIPPINES ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 991 PHILIPPINES MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 992 PHILIPPINES ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 993 PHILIPPINES OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 994 PHILIPPINES VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 995 PHILIPPINES CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 996 PHILIPPINES OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 997 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 998 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 999 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1000 PHILIPPINES TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1001 PHILIPPINES LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1002 PHILIPPINES INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1003 PHILIPPINES ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1004 PHILIPPINES OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1005 PHILIPPINES REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1006 PHILIPPINES VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1007 PHILIPPINES INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1008 PHILIPPINES ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1009 PHILIPPINES VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1010 PHILIPPINES OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1011 PHILIPPINES OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1012 PHILIPPINES RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1013 SINGAPORE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1014 SINGAPORE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1015 SINGAPORE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1016 SINGAPORE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1017 SINGAPORE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1018 SINGAPORE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1019 SINGAPORE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1020 SINGAPORE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1021 SINGAPORE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1022 SINGAPORE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1023 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1024 SINGAPORE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1025 SINGAPORE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1026 SINGAPORE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1027 SINGAPORE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1028 SINGAPORE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1029 SINGAPORE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1030 SINGAPORE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1031 SINGAPORE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1032 SINGAPORE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1033 SINGAPORE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1034 SINGAPORE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1035 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1036 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1037 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1038 SINGAPORE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1039 SINGAPORE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1040 SINGAPORE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1041 SINGAPORE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1042 SINGAPORE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1043 SINGAPORE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1044 SINGAPORE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1045 SINGAPORE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1046 SINGAPORE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1047 SINGAPORE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1048 SINGAPORE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1049 SINGAPORE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1050 SINGAPORE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1051 REST OF ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1052 SOUTH AMERICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 1053 SOUTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1054 SOUTH AMERICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1055 SOUTH AMERICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1056 SOUTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1057 SOUTH AMERICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1058 SOUTH AMERICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1059 SOUTH AMERICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1060 SOUTH AMERICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1061 SOUTH AMERICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1062 SOUTH AMERICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1063 SOUTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1064 SOUTH AMERICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1065 SOUTH AMERICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1066 SOUTH AMERICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1067 SOUTH AMERICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1068 SOUTH AMERICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1069 SOUTH AMERICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1070 SOUTH AMERICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1071 SOUTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1072 SOUTH AMERICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1073 SOUTH AMERICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1074 SOUTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1075 SOUTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1076 SOUTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1077 SOUTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1078 SOUTH AMERICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1079 SOUTH AMERICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1080 SOUTH AMERICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1081 SOUTH AMERICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1082 SOUTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1083 SOUTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1084 SOUTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1085 SOUTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1086 SOUTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1087 SOUTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1088 SOUTH AMERICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1089 SOUTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1090 SOUTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1091 BRAZIL OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1092 BRAZIL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1093 BRAZIL SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1094 BRAZIL OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1095 BRAZIL VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1096 BRAZIL REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1097 BRAZIL GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1098 BRAZIL DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1099 BRAZIL OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1100 BRAZIL OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1101 BRAZIL DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1102 BRAZIL ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1103 BRAZIL ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1104 BRAZIL PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1105 BRAZIL BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1106 BRAZIL ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1107 BRAZIL MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1108 BRAZIL ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1109 BRAZIL OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1110 BRAZIL VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1111 BRAZIL CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1112 BRAZIL OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1113 BRAZIL DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1114 BRAZIL DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1115 BRAZIL DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1116 BRAZIL TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1117 BRAZIL LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1118 BRAZIL INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1119 BRAZIL ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1120 BRAZIL OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1121 BRAZIL REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1122 BRAZIL VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1123 BRAZIL INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1124 BRAZIL ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1125 BRAZIL VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1126 BRAZIL OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1127 BRAZIL OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1128 BRAZIL RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1129 ARGENTINA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1130 ARGENTINA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1131 ARGENTINA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1132 ARGENTINA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1133 ARGENTINA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1134 ARGENTINA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1135 ARGENTINA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1136 ARGENTINA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1137 ARGENTINA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1138 ARGENTINA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1139 ARGENTINA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1140 ARGENTINA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1141 ARGENTINA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1142 ARGENTINA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1143 ARGENTINA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1144 ARGENTINA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1145 ARGENTINA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1146 ARGENTINA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1147 ARGENTINA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1148 ARGENTINA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1149 ARGENTINA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1150 ARGENTINA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1151 ARGENTINA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1152 ARGENTINA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1153 ARGENTINA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1154 ARGENTINA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1155 ARGENTINA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1156 ARGENTINA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1157 ARGENTINA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1158 ARGENTINA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1159 ARGENTINA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1160 ARGENTINA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1161 ARGENTINA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1162 ARGENTINA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1163 ARGENTINA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1164 ARGENTINA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1165 ARGENTINA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1166 ARGENTINA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1167 REST OF SOUTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1168 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 1169 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1170 MIDDLE EAST AND AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1171 MIDDLE EAST AND AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1172 MIDDLE EAST AND AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1173 MIDDLE EAST AND AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1174 MIDDLE EAST AND AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1175 MIDDLE EAST AND AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1176 MIDDLE EAST AND AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1177 MIDDLE EAST AND AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1178 MIDDLE EAST AND AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1179 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1180 MIDDLE EAST AND AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1181 MIDDLE EAST AND AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1182 MIDDLE EAST AND AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1183 MIDDLE EAST AND AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1184 MIDDLE EAST AND AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1185 MIDDLE EAST AND AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1186 MIDDLE EAST AND AFRICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1187 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1188 MIDDLE EAST AND AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1189 MIDDLE EAST AND AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1190 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1191 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1192 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1193 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1194 MIDDLE EAST AND AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1195 MIDDLE EAST AND AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1196 MIDDLE EAST AND AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1197 MIDDLE EAST AND AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1198 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1199 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1200 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1201 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1202 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1203 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1204 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1205 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1206 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1207 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1208 SOUTH AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1209 SOUTH AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1210 SOUTH AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1211 SOUTH AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1212 SOUTH AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1213 SOUTH AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1214 SOUTH AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1215 SOUTH AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1216 SOUTH AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1217 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1218 SOUTH AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1219 SOUTH AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1220 SOUTH AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1221 SOUTH AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1222 SOUTH AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1223 SOUTH AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1224 SOUTH AFRICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1225 SOUTH AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1226 SOUTH AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1227 SOUTH AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1228 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1229 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1230 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1231 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1232 SOUTH AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1233 SOUTH AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1234 SOUTH AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1235 SOUTH AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1236 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1237 SOUTH AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1238 SOUTH AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1239 SOUTH AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1240 SOUTH AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1241 SOUTH AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1242 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1243 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1244 SOUTH AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1245 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1246 SAUDI ARABIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1247 SAUDI ARABIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1248 SAUDI ARABIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1249 SAUDI ARABIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1250 SAUDI ARABIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1251 SAUDI ARABIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1252 SAUDI ARABIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1253 SAUDI ARABIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1254 SAUDI ARABIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1255 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1256 SAUDI ARABIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1257 SAUDI ARABIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1258 SAUDI ARABIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1259 SAUDI ARABIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1260 SAUDI ARABIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1261 SAUDI ARABIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1262 SAUDI ARABIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1263 SAUDI ARABIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1264 SAUDI ARABIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1265 SAUDI ARABIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1266 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1267 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1268 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1269 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1270 SAUDI ARABIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1271 SAUDI ARABIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1272 SAUDI ARABIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1273 SAUDI ARABIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1274 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1275 SAUDI ARABIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1276 SAUDI ARABIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1277 SAUDI ARABIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1278 SAUDI ARABIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1279 SAUDI ARABIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1280 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1281 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1282 SAUDI ARABIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1283 U.A.E OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1284 U.A.E DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1285 U.A.E SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1286 U.A.E OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1287 U.A.E VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1288 U.A.E REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1289 U.A.E GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1290 U.A.E DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1291 U.A.E OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1292 U.A.E OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1293 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1294 U.A.E ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1295 U.A.E ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1296 U.A.E PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1297 U.A.E BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1298 U.A.E ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1299 U.A.E MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1300 U.A.E ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1301 U.A.E OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1302 U.A.E VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1303 U.A.E CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1304 U.A.E OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1305 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1306 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1307 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1308 U.A.E TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1309 U.A.E LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1310 U.A.E INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1311 U.A.E ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1312 U.A.E OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1313 U.A.E REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1314 U.A.E VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1315 U.A.E INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1316 U.A.E ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1317 U.A.E VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1318 U.A.E OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1319 U.A.E OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1320 U.A.E RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1321 EGYPT OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1322 EGYPT DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1323 EGYPT SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1324 EGYPT OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1325 EGYPT VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1326 EGYPT REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1327 EGYPT GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1328 EGYPT DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1329 EGYPT OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1330 EGYPT OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1331 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1332 EGYPT ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1333 EGYPT ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1334 EGYPT PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1335 EGYPT BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1336 EGYPT ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1337 EGYPT MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1338 EGYPT ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1339 EGYPT OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1340 EGYPT VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1341 EGYPT CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1342 EGYPT OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1343 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1344 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1345 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1346 EGYPT TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1347 EGYPT LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1348 EGYPT INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1349 EGYPT ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1350 EGYPT OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1351 EGYPT REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1352 EGYPT VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1353 EGYPT INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1354 EGYPT ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1355 EGYPT VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1356 EGYPT OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1357 EGYPT OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1358 EGYPT RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1359 ISRAEL OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1360 ISRAEL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1361 ISRAEL SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 1362 ISRAEL OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1363 ISRAEL VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1364 ISRAEL REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1365 ISRAEL GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1366 ISRAEL DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1367 ISRAEL OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1368 ISRAEL OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1369 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1370 ISRAEL ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1371 ISRAEL ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1372 ISRAEL PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1373 ISRAEL BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1374 ISRAEL ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1375 ISRAEL MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1376 ISRAEL ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1377 ISRAEL OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1378 ISRAEL VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1379 ISRAEL CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 1380 ISRAEL OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 1381 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 1382 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 1383 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1384 ISRAEL TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1385 ISRAEL LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1386 ISRAEL INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1387 ISRAEL ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 1388 ISRAEL OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1389 ISRAEL REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1390 ISRAEL VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1391 ISRAEL INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1392 ISRAEL ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1393 ISRAEL VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 1394 ISRAEL OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 1395 ISRAEL OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1396 ISRAEL RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 1397 REST OF MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

Список рисунков

FIGURE 1 GLOBAL OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 GLOBAL OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL OPHTHALMOLOGY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE GLOBAL OPHTHALMOLOGY MARKET, BY PRODUCTS

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE GLOBAL OPHTHALMOLOGY MARKET FROM 2025 TO 2032

FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL OPHTHALMOLOGY MARKET IN 2025 AND 2032

FIGURE 16 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL OPHTHALMOLOGY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 17 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR OPHTHALMOLOGY MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 18 DROC ANALYSIS

FIGURE 19 GLOBAL OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024

FIGURE 20 GLOBAL OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)

FIGURE 21 GLOBAL OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)

FIGURE 22 GLOBAL OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 23 GLOBAL OPHTHALMOLOGY MARKET: BY DISEASES, 2024

FIGURE 24 GLOBAL OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)

FIGURE 25 GLOBAL OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)

FIGURE 26 GLOBAL OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 27 GLOBAL OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024

FIGURE 28 GLOBAL OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)

FIGURE 29 GLOBAL OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)

FIGURE 30 GLOBAL OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE

FIGURE 31 GLOBAL OPHTHALMOLOGY MARKET: BY END USER, 2024

FIGURE 32 GLOBAL OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)

FIGURE 33 GLOBAL OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)

FIGURE 34 GLOBAL OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 GLOBAL OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024

FIGURE 36 GLOBAL OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)

FIGURE 37 GLOBAL OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 38 GLOBAL OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 GLOBAL OPHTHALMOLOGY MARKET SNAPSHOT

FIGURE 40 GLOBAL OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

FIGURE 41 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

FIGURE 42 EUROPE OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

FIGURE 43 ASIA-PACIFIC OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

View Detailed Information

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

What are the growth drivers of the Ophthalmology Market?

The Rise in traumatic injuries & Rising prevalence of ophthalmic disorders are the growth drivers of the Ophthalmology Market.

What are the factors on which the Ophthalmology Market research is based on?

The products, disease, prescription mode, drug type, route of administration, end user, and distribution channel are the factors on which the Ophthalmology Market research is based.

Which are the major companies in the Ophthalmology Market?

The major companies in the Ophthalmology Market are Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Carl Zeiss Meditec AG, AbbVie Inc., EssilorLuxottica, NIDEK CO., LTD., TOPCON CORPORATION, Glaukos Corporation., STAAR SURGICAL, Metall Zug AG, Sun Pharmaceutical Industries Ltd., Lumenis Be Ltd., Pfizer Inc., and Ziemer Ophthalmic Systems AG.

Мировой рынок офтальмологии — тенденции отрасли и прогноз до 2032 года

Мировой рынок офтальмологии — тенденции отрасли и прогноз до 2032 года

Global Ophthalmology Market

CAGR : 6.70 %

Анализ мирового рынка офтальмологии

Размер мирового рынка офтальмологии

Масштаб мирового рынка офтальмологии

Региональный анализ мирового рынка офтальмологии

Доля на мировом рынке офтальмологии

Последние разработки на мировом рынке офтальмологии

Get online access to the report on the World's First Market Intelligence Cloud

Содержание

Список таблиц

Список рисунков

Методология исследования

Доступна настройка

Часто задаваемые вопросы

Просмотр связанных страниц

Product manager, Fujifilms

Investor relations, GE Healthcare

Market Analyst, Medincell

Andrew - Senior Global Marketing Manager, Medtronic (US)

Amarildo - Manager, Global Strategic Alignment MasterCard

Tor Hammer Green Nexus LLc

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,

Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions

Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

Business Intelligence and Analytics, Ipsen Biopharm Limited

Competition Analyst, Basler Web

Marketing Director, Buhler Group

COO, A global leader providing Drug Delivery Services

Marketing Director, Philips Healthcare

Product manager, Fujifilms

Investor relations, GE Healthcare

Market Analyst, Medincell

Andrew - Senior Global Marketing Manager, Medtronic (US)

Amarildo - Manager, Global Strategic Alignment MasterCard

Tor Hammer Green Nexus LLc

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,

Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions

Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

Business Intelligence and Analytics, Ipsen Biopharm Limited

Competition Analyst, Basler Web

Marketing Director, Buhler Group

COO, A global leader providing Drug Delivery Services

Marketing Director, Philips Healthcare